Your browser doesn't support javascript.
loading
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab.
Gillies, Mark C; Campain, Anna; Walton, Richard; Simpson, Judy M; Arnold, Jennifer J; Guymer, Robyn H; McAllister, Ian L; Hunyor, Alex P; Essex, Rohan W; Morlet, Nigel; Barthelmes, Daniel.
Afiliación
  • Gillies MC; The Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Campain A; The Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Walton R; The Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Simpson JM; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
  • Arnold JJ; Marsden Eye Specialists, Parramatta, New South Wales, Australia.
  • Guymer RH; Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
  • McAllister IL; Lions Eye Institute, Centre for Ophthalmology and Vision Science, University of Western Australia, Crawley, Western Australia.
  • Hunyor AP; The Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Retina Associates, Chatswood, New South Wales, Australia.
  • Essex RW; Academic Unit of Ophthalmology, Australian National University, Acton, Australian Capital Territory.
  • Morlet N; University of Western Australia Department of Population Health, Perth, Western Australia.
  • Barthelmes D; The Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: daniel.barthelmes@usz.ch.
Ophthalmology ; 122(3): 589-594.e1, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25458197
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Degeneración Macular Húmeda / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmology Año: 2015 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Degeneración Macular Húmeda / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmology Año: 2015 Tipo del documento: Article País de afiliación: Australia